A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fenoterol
Fluticasone furoate
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluticasone furoate.
Fenoterol
Certolizumab pegol
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Certolizumab pegol.
Fenoterol
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Carfilzomib.
Fenoterol
Ruxolitinib
The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Carfilzomib.
Fenoterol
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Carfilzomib.
Fenoterol
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Carfilzomib.
Fenoterol
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Carfilzomib.
Fenoterol
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Carfilzomib.
Fenoterol
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Carfilzomib.
Fenoterol
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Carfilzomib.
Fenoterol
Rilonacept
The risk or severity of adverse effects can be increased when Rilonacept is combined with Carfilzomib.
Fenoterol
Tocilizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Carfilzomib.
Fenoterol
Canakinumab
The risk or severity of adverse effects can be increased when Canakinumab is combined with Carfilzomib.
Fenoterol
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Carfilzomib.
Fenoterol
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Carfilzomib.
Fenoterol
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Carfilzomib.
Fenoterol
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Carfilzomib.
Fenoterol
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Carfilzomib.
Fenoterol
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Carfilzomib.
Fenoterol
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Carfilzomib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3